Goszcz, Katarzyna by unknown
    UHI Research Database pdf download summary
The polyphenol delphinidin induces antioxidant effects in human umbilical vein
endothelial cells through activation of endogenous glutathione: importance of using
relevant concentration in in vitro systems
Goszcz, Katarzyna; Duthie, Garry; Stewart, Derek; Megson, Ian
Published in:
Heart
Publication date:
2017
Publisher rights:
© 2017, Published by the BMJ Publishing Group Limited.
The re-use license for this item is:
CC BY
The Document Version you have downloaded here is:
Publisher's PDF, also known as Version of record
The final published version is available direct from the publisher website at:
10.1136/heartjnl-2017-311433.20
Link to author version on UHI Research Database
Citation for published version (APA):
Goszcz, K., Duthie, G., Stewart, D., & Megson, I. (2017). The polyphenol delphinidin induces antioxidant effects
in human umbilical vein endothelial cells through activation of endogenous glutathione: importance of using
relevant concentration in in vitro systems. Heart, 103(Issue Suppl 2; A8-A9), 1. DOI: 10.1136/heartjnl-2017-
311433.20
General rights
Copyright and moral rights for the publications made accessible in the UHI Research Database are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights:
1) Users may download and print one copy of any publication from the UHI Research Database for the purpose of private study or research.
2) You may not further distribute the material or use it for any profit-making activity or commercial gain
3) You may freely distribute the URL identifying the publication in the UHI Research Database
Take down policy
If you believe that this document breaches copyright please contact us at RO@uhi.ac.uk providing details; we will remove access to the work
immediately and investigate your claim.
Download date: 18. Apr. 2019
the emergence and growth of collateral arteries in the thigh
(upstream of the ligation point).
Conclusion A pre-existing collateral circulation provides the
residual blood supply after femoral ligation. A rapid increase
in the diameter of a small number of collateral arteries
appeared to be the major mechanism for acute restoration of
blood supply to the ischaemic lower leg and foot pad. Future
work will use histology and immunohistochemistry to investi-
gate the role of angiogenesis in reperfusion following femoral
ligation.
18 TOWARDS NON-INVASIVE CHARACTERISATION OF RE-
ENDOTHELIALISATION AND RESTENOSIS FOLLOWING
CORONARY STENTING: AN IN VITRO INVESTIGATION
USING IMPEDANCE SPECTROSCOPY
Ian Holland*, Christopher McCormick, Patricia Connolly. Department of Biomedical
Engineering, University of Strathclyde, Glasgow, UK
10.1136/heartjnl-2017-311433.18
Following the permanent implantation of a coronary stent,
optimal arterial wall healing is characterised by re-endotheliali-
sation, the regrowth of a functional Endothelial Cell (EC)
monolayer over the exposed stent surface, which reduces the
risk of thrombosis. However restenosis, arising from the pro-
liferation and migration of medial Smooth Muscle Cells
(SMCs) can cause luminal narrowing to reoccur. Previous
research has suggested that the stent itself could be used as an
electrode and, when combined with non-invasive impedance
spectroscopy techniques, monitor post stenting recovery. This
could then inform clinicians on cell regrowth without the
need for invasive imaging techniques. In this study we investi-
gated the feasibility of this concept using two in-vitro models
representing the cellular regrowth scenarios: re-endothelialisa-
tion and restenosis.
Primary porcine ECs and SMCs were seeded onto platinum
electrodes and electrical impedance spectroscopy measurements
were made for up to 10 days in the frequency range 1 KHz
to 100 KHz. Endothelium function was assessed through the
measurement of the impedance response of confluent EC
monolayers to the addition of a gap junction enhancer, dipyri-
damole, or an inhibitor (heptanol or carbenoxolone).
Our results show that confluent, stent surface comparable
populations of SMCs and ECs give rise to distinct impedance
signatures, providing a novel method of non-invasively charac-
terising these cell types. Gap junction inhibition of EC mono-
layers dose dependently reduced total impedance. Conversely
dipyridamole’s enhancing effect on gap junction formation
caused an increase in total impedance. These novel findings
show the importance of intercellular gap junction communica-
tion in maintaining EC barrier function. Our current work is
focused on the translation of this technology towards in-vivo
monitoring of in-stent restenosis and recovery of a functional
endothelium.
Acknowledgements this study was funded by the UK Engineer-
ing and Physical Sciences Research Council (EP/F50036X/1)
and is the subject of granted and pending patents at the Uni-
versity of Strathclyde.
19 ADVERSE CARDIAC REMODELLING UNDER PRESSURE
OVERLOAD. A MAGNETIC RESONANCE IMAGING STUDY
IN MICE
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Pressure overload, a hallmark of valvular heart disease and
hypertension, is the leading cause of heart failure. With the
progressive nature of this condition a better understanding of
the process underlying the transition to heart failure is vital.
Recent studies suggest that interstitial myocardial fibrosis
occurs early in this transition and has a profound effect on
cardiac function. The recently developed T1-mapping Cardio-
vascular Magnetic Resonance Imaging (CMR) technique has
the potential to quantify the extracellular volume fraction
(ECV) and therefore evaluate the expansion of the extracellu-
lar matrix (primarily diffuse fibrosis) over time.
We aimed to assess the feasibility of CMR (including func-
tional and ECV imaging) to monitor cardiac remodelling using
an animal model of pressure overload heart disease.
Fifteen mice were subjected to a 6 week Angiotensin-II
infusion (AngII). CMR (cine and T1 mapping) was performed
before and following Angiotensin II infusion at 2, 4 and 6
weeks. ECV was calculated from the T1 relaxation times pre
and post-contrast infusion).
Mean blood pressure increased from 65±12 (baseline) to
84±14 mmHg (p<0.001) and ECV increased from 24.28%
±3.35% (baseline) to 30.03%±5.34% after 2 weeks of AngII
(p=0.011). ECV plateaued at 4 and 6 weeks and stayed sig-
nificantly higher compared to baseline (p=0.001). Cine imag-
ing revealed left ventricular (LV) hypertrophy during infusion
which remained stable at 4 and 6 weeks. Interestingly, systolic
function was maintained after 2 and 4 weeks of AngII but
was impaired at six weeks (EF 56.3% compared to 64.4% at
baseline and 59.8%; 60.7%, at 2 and 4 weeks (p=0.014).
This drop in cardiac performance was accompanied by a trend
towards LV dilatation at 6 weeks compared to baseline (LV
end diastolic volume 68 ml vs 63 ml, p=0.056).
Prolonged pressure overload results in ECV expansion, LV
hypertrophy and subsequent systolic dysfunction. T1 mapping
CMR shows promise in monitoring this transition.
20 THE POLYPHENOL DELPHINIDIN INDUCES ANTIOXIDANT
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Polyphenols are regarded to have a wide range of health-pro-
moting effects. Increased consumption of polyphenol-rich food
is known to be associated with numerous cardioprotective
effects. Polyphenols have been shown to improve endothelial
function, inhibit abnormal platelet aggregation, reduce inflam-
mation and improve plasma lipid profiles. Moreover, polyphe-
nols have been widely recognised as powerful antioxidants.
Given that oxidative stress plays a key role in initiation and
progression of atherosclerosis, antioxidant therapy with poly-
phenols has potential. However, the concentrations required
to mediate sufficient antioxidant effect appear to be unattain-
able under in vivo conditions. Polyphenols are characterised
by poor absorption, rapid degradation and extensive metabo-
lism, culminating in poor bioavailability (~1 mM). In addition,
they can also exhibit paradoxical pro-oxidant activities.
Spectrophotometric and mass spectrometry (LC-MS/MS)
analysis of the phenolic compound, delphinidin, confirmed its
low stability and rapid degradation (t1/2 ~30 min) under phys-
iologically relevant conditions. Delphinidin degraded to smaller
phenolics: gallic acid and phloroglucinol aldehyde. Moreover,
both the parent compound and its main metabolite, gallic
acid, generated oxygen-centred free radicals at concen-
trations10 mM, as determined by electron paramagnetic reso-
nance spectrometry (EPR). Interestingly, the tested phenolics
offered significant protection to human umbilical endothelial
cells (HUVECs) against chemically induced oxidative stress.
The protective effect of both phenolics were hormesic in pro-
file; supraphysiological concentrations (100 mM) were cyto-
toxic, whereas physiologically relevant concentrations (100 nM
– 1 mM) were protective against oxidative stress. The observed
protection was associated with increased intracellular
glutathione.
The results confirm that physiologically relevant concentra-
tions of delphinidin and its major metabolite, gallic acid, are
sufficient to induce antioxidant benefits, but via an indirect,
xenobiotic mechanism that induces upregulation of endoge-
nous antioxidant capacity. The findings emphasis that stability,
rate of absorption, distribution and metabolism of phenolic
compound needs to be taken into consideration when design-
ing in vitro studies to test their mechanism of action.
21 THE ROLE OF OSTEOPONTIN IN LEFT VENTRICULAR
HYPERTROPHY
Tamara P Martin*, Maria Cobo Andrade, Christopher Loughrey, Delyth Graham, Martin
W McBride. Institute of Cardiovascular and Medical Sciences, University of Glasgow, UK
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The stroke-prone spontaneously hypertensive rat (SHRSP)
develops increased left ventricular mass index (LVMI) prior to
the onset of hypertension, making it a fundamental model to
better understand human cardiovascular disease. We identified
a quantitative trait locus (QTL) for LVMI on chromosome 14
and, by using chromosome 14 congenic strains and gene
profiling, have identified osteopontin (Spp1) as a positional
candidate gene. Here, we show 1) that Spp1 may promote
cardiac remodelling via extracellular vesicle (EV) signalling and
2) provide phenotypic and molecular characterisation of a
CRISPR/Cas9 Spp1-knockout rat on the SHRSP genetic back-
ground (SHRSP-Spp1 KO). 1) Briefly, H9c2 cells were seeded
24 hours prior to transfection with Spp1 cloned into pcDNA1
(5 ug) for 48 hours. EVs were isolated from conditioned
media (CM) via ultracentrifugation, verified by NanoSight, re-
suspended in PBS and placed onto fresh H9c2 cells for
48 hours. Crystal violet stained H9c2 cells were analysed
using ImageJ. Cells transfected with Spp1 cDNA derived from
the SHRSP rat displayed a significant increase in cell size
compared with cells transfected with empty pcDNA vector
(pcDNA 107.9±1.4 vs SHRSP 141.8±2.3, p<0.001). Similarly,
conditioned media (CM) taken from SHRSP transfected cells
produced a significant increase in fresh H9c2 size compared
with empty pcDNA vector (pcDNA 67.9±1.1 vs SHRSP 133.0
±2.9, p<0.001). EVs isolated from media conditioned from
cells transfected with SHRSP significantly increased fresh
H9c2 cell size compared to empty pcDNA vector (pcDNA
96.6±1.5 vs SHRSP 152.9±2.6, p<0.001). Collectively these
data suggest that over-expression of Spp1 promotes an
increase in cell size via EV signalling. Further studies are
required to characterise EV content and the downstream
mechanisms leading to hypertrophy. 2) Hemizygous rats were
bred and confirmation of Spp1 gene knockout was confirmed
in resultant pups by a restriction fragment length polymor-
phism, Sanger sequencing and ELISA. Echocardiography and
radiotelemetry were used to assess cardiac function and blood
pressure, respectively. Male rats were assessed over 5–16
weeks of age. Cardiac fibrosis was assessed by picro-sirus red
staining of total collagen and Col1a1 mRNA expression was
assessed by qRT-PCR. LVMI, calculated from either echocar-
diography or post-mortem, showed no significant difference in
SHRSP-Spp1 KO compared to its SHRSP littermate controls
(p>0.05). Similarly, no difference was observed in LV relative
wall thickness in SHRSP-Spp1 KO compared to SHRSP
(p>0.05). Cardiac fibrosis assessed by both histology and
qRT-PCR showed no significant difference in SHRSP-Spp1 KO
compared to SHRSP (p>0.05). Overall, these data suggest
that the cardiac phenotype of the SHRSP-Spp1 KO rat is no
different from SHRSP at baseline. Further studies are required
to determine whether a cardiac stress will unmask a difference
in phenotype in the SHRSP-Spp1 KO compared to littermate
controls.
22 5a-TETRAHYDROCORTISONE EXHIBITS TOPICAL ANTI-
INFLAMMATORY ACTION WITH LIMITED ADVERSE
EFFECTS ON ANGIOGENESIS
Amber J Abernethie*, Annalisa Gastaldello, Dawn EW Livingstone, Brian R Walker, Patrick
WF Hadoke, Ruth Andrew. Centre for Cardiovascular Science, Queens Medical Research
Centre, University of Edinburgh, Scotland, UK
10.1136/heartjnl-2017-311433.22
Glucocorticoids (GC) are potent anti-inflammatory drugs but
have debilitating side effects. A safer alternative is required
and 5a-tetrahydrocorticosterone (5aTHB, a metabolite of the
natural rodent glucocorticoid corticosterone) may provide a
solution. 5aTHB is anti-inflammatory in vivo but with fewer
systemic adverse effects. It is rapidly cleared from systemic cir-
culation and is therefore being investigated for topical applica-
tion. Topical steroids additionally impair wound healing,
largely due to the inhibition of angiogenesis and of collagen
deposition. Here, the effects of 5aTHB on processes involved
with wound repair were investigated.
Angiogenesis was assessed using two murine models. In the
first, sponges containing vehicle, 5aTHB (3 mg or 15 mg), or
corticosterone (3 mg) were implanted subcutaneously in
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